Drug intelligence / Profile preview

ExoGiov

Development stage
Unknown
Lead developer
Ambiotech
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

ExoGiov is an extracellular vesicle (EV)-based product developed by Ambiotech using its proprietary Bio-Pulsed technology. The active ingredient consists of bio-pulsed exosomes derived from Specific Pathogen Free (SPF) chicken embryonic mesenchymal stem cells. The product is indicated for multiple cosmetic and aesthetic applications, including hair loss (alopecia), skin aging, and wound healing. The Bio-Pulsed technology enhances exosome production and potency, increasing protein and miRNA content compared to conventional methods. ExoGiov works by promoting tissue repair and regeneration through extracellular vesicle-mediated signaling, delivering growth factors and anti-inflammatory agents that stimulate the expression of Type I collagen, Type III collagen, and elastin.

Brand names
ExoGiovLA EXO愛奇芙
Other names
Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles
02

Targets

COL1 (Collagen type I)ELN (Elastin)

Beyond the preview

Go deeper on ExoGiov.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoGiov.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call